Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017

Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and...

Full description

Saved in:
Bibliographic Details
Published inRespiratory research Vol. 21; no. 1; pp. 49 - 13
Main Authors Xie, Min, Liu, Xiansheng, Cao, Xiaopei, Guo, Mingzhou, Li, Xiaochen
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 11.02.2020
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence. The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI.
AbstractList Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence. The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI.
Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated.BACKGROUNDChronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated.Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence.METHODSBased on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence.The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI.RESULTThe total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI.In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI.CONCLUSIONSIn 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI.
Background Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Methods Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence. Result The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. Conclusions In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI.
Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence. The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI.
Background Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Methods Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence. Result The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. Conclusions In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI. Keywords: Global, Chronic respiratory diseases, Chronic obstructive pulmonary disease, Asthma, Incidence
Abstract Background Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Methods Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence. Result The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. Conclusions In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI.
ArticleNumber 49
Audience Academic
Author Xie, Min
Li, Xiaochen
Cao, Xiaopei
Liu, Xiansheng
Guo, Mingzhou
Author_xml – sequence: 1
  givenname: Min
  surname: Xie
  fullname: Xie, Min
– sequence: 2
  givenname: Xiansheng
  surname: Liu
  fullname: Liu, Xiansheng
– sequence: 3
  givenname: Xiaopei
  surname: Cao
  fullname: Cao, Xiaopei
– sequence: 4
  givenname: Mingzhou
  surname: Guo
  fullname: Guo, Mingzhou
– sequence: 5
  givenname: Xiaochen
  orcidid: 0000-0002-2161-6168
  surname: Li
  fullname: Li, Xiaochen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32046720$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1r3DAQhk1JaT7aH9BLMfTSi1ONZUnWpRBCPwKBXrbQm5Cl0UaLLW0lbyD_vnI2TbOhFB0kjZ55hxm9p9VRiAGr6i2Qc4Cef8zQSgoNaUlTTtD0L6oT6DhrpKQ_j56cj6vTnDeEgOgFe1Ud05Z0XLTkpFqtEgabax_qbcJbPWIwWOtgS8R4e3-LrjY3KQZv6oR565OeY7qrrc-oM-bapTjVICWp51i3pcjr6qXTY8Y3D_tZ9ePL59Xlt-b6-9ery4vrxjBO5qa3fKCD7jQbbIstBcLaAajUwLh2tqdCcMvAgpNOoJOWc26FQD5gNwgy0LPqaq9ro96obfKTTncqaq_uAzGtlU6zNyMqyawz0krBCXaUQc94LyQTaDvuqOFF69Nea7sbJrQGw5z0eCB6-BL8jVrHWyUIdAJkEfjwIJDirx3mWU0-GxxHHTDusmop66BrBV3Q98_QTdylUEa1UKKFrpfsL7Uuv6J8cLHUNYuouuDAqeSdhEKd_4Mqy-LkTfGL8yV-kPDuaaOPHf7xRAFgD5gUc07oHhEgavGd2vtOFd-pxXeqLzniWY7xs559XGblx_9k_gZFc9jZ
CitedBy_id crossref_primary_10_1007_s00420_023_01991_8
crossref_primary_10_1016_j_intimp_2024_113979
crossref_primary_10_1016_j_lanepe_2021_100122
crossref_primary_10_3389_fmed_2024_1471527
crossref_primary_10_1007_s11095_022_03194_1
crossref_primary_10_1007_s11356_023_27503_2
crossref_primary_10_1371_journal_pcbi_1012680
crossref_primary_10_4103_joa_joa_245_22
crossref_primary_10_3389_fphys_2023_1273645
crossref_primary_10_1177_13591053241272150
crossref_primary_10_2147_COPD_S304527
crossref_primary_10_3389_fpubh_2022_1006536
crossref_primary_10_1002_adbi_202300165
crossref_primary_10_1016_j_ijid_2022_10_013
crossref_primary_10_1109_OJEMB_2024_3360688
crossref_primary_10_1136_bmjresp_2021_000919
crossref_primary_10_7759_cureus_70718
crossref_primary_10_3390_ijms21082765
crossref_primary_10_3390_medicina58060817
crossref_primary_10_3390_medicina57111265
crossref_primary_10_1002_ppul_25849
crossref_primary_10_1039_D3LC00894K
crossref_primary_10_1109_TBME_2022_3145688
crossref_primary_10_1007_s10916_025_02154_7
crossref_primary_10_1002_med_21956
crossref_primary_10_1016_j_ajt_2022_11_008
crossref_primary_10_15857_ksep_2024_00115
crossref_primary_10_26724_2079_8334_2023_3_85_31_35
crossref_primary_10_1016_j_heliyon_2023_e19976
crossref_primary_10_1172_JCI150473
crossref_primary_10_1016_j_sleep_2020_07_012
crossref_primary_10_1002_iub_2559
crossref_primary_10_4103_lungindia_lungindia_999_20
crossref_primary_10_1177_14799731251316891
crossref_primary_10_1186_s12890_024_02903_3
crossref_primary_10_1016_j_socscimed_2024_116613
crossref_primary_10_3390_healthcare11152171
crossref_primary_10_1002_ajim_23519
crossref_primary_10_3390_jcm10132889
crossref_primary_10_1109_JTEHM_2022_3193575
crossref_primary_10_1183_23120541_00597_2024
crossref_primary_10_3390_ijerph17165788
crossref_primary_10_60042_2949_2165_2024_2_1_7_24
crossref_primary_10_2139_ssrn_3745183
crossref_primary_10_3389_fmed_2022_1069929
crossref_primary_10_1093_qjmed_hcae010
crossref_primary_10_1186_s12890_022_02059_y
crossref_primary_10_1002_adbi_202101139
crossref_primary_10_1186_s12889_025_22193_6
crossref_primary_10_1007_s43450_022_00286_2
crossref_primary_10_1097_CM9_0000000000002855
crossref_primary_10_1002_hsr2_575
crossref_primary_10_1136_bmjresp_2023_002103
crossref_primary_10_1007_s13721_023_00419_0
crossref_primary_10_1177_14799731241233301
crossref_primary_10_1177_1357633X20970402
crossref_primary_10_1007_s00210_023_02830_w
crossref_primary_10_1016_j_jddst_2022_103659
crossref_primary_10_1186_s12889_025_22272_8
crossref_primary_10_1016_j_mayocp_2022_09_007
crossref_primary_10_1016_j_resp_2024_104368
crossref_primary_10_1186_s12889_023_15553_7
crossref_primary_10_1016_j_pulmoe_2022_07_007
crossref_primary_10_7759_cureus_49230
crossref_primary_10_18273_revmed_v36n1_2023001
crossref_primary_10_3390_geriatrics9020034
crossref_primary_10_1007_s00484_023_02504_5
crossref_primary_10_1007_s11356_022_23094_6
crossref_primary_10_1136_thoraxjnl_2020_216732
crossref_primary_10_29413_ABS_2023_8_3_22
crossref_primary_10_1152_ajplung_00207_2020
crossref_primary_10_2147_PPA_S417375
crossref_primary_10_3390_biomedicines12030488
crossref_primary_10_36290_csf_2020_025
crossref_primary_10_3390_jcm11164864
crossref_primary_10_1016_j_fbio_2024_105201
crossref_primary_10_1016_j_horiz_2023_100078
crossref_primary_10_1109_TCSII_2020_3046919
crossref_primary_10_3390_nu13114055
crossref_primary_10_3390_cells10123437
crossref_primary_10_1016_j_ejphar_2024_176846
crossref_primary_10_1208_s12249_024_02776_z
crossref_primary_10_1080_10408398_2021_1915744
crossref_primary_10_1080_23748834_2022_2094884
crossref_primary_10_4103_indianjpsychiatry_indianjpsychiatry_25_22
crossref_primary_10_1186_s12931_023_02353_1
crossref_primary_10_3389_fphys_2020_613398
crossref_primary_10_1016_j_it_2024_06_005
crossref_primary_10_1016_j_jddst_2024_105381
crossref_primary_10_1152_ajplung_00103_2021
crossref_primary_10_1016_j_pce_2022_103232
crossref_primary_10_3390_antiox12061140
crossref_primary_10_1016_j_hjc_2022_10_004
crossref_primary_10_1016_j_hermed_2023_100685
crossref_primary_10_1186_s12890_021_01745_7
crossref_primary_10_1007_s10517_022_05566_4
crossref_primary_10_4103_mtsm_mtsm_15_23
crossref_primary_10_4046_trd_2023_0100
crossref_primary_10_1186_s12889_020_10042_7
crossref_primary_10_1186_s12913_023_10525_4
crossref_primary_10_18632_aging_204358
crossref_primary_10_1080_09638288_2023_2233899
crossref_primary_10_2217_nnm_2021_0437
crossref_primary_10_3389_fcell_2023_1149499
crossref_primary_10_1016_j_ecoenv_2024_116740
crossref_primary_10_1016_j_opresp_2023_100245
crossref_primary_10_1016_j_heliyon_2023_e19596
crossref_primary_10_1016_j_jnutbio_2021_108632
crossref_primary_10_1136_bmjopen_2023_083795
crossref_primary_10_4103_ecdt_ecdt_5_22
crossref_primary_10_21053_ceo_2021_02054
crossref_primary_10_3390_ijms24129913
crossref_primary_10_2174_1381612826999201116161143
crossref_primary_10_1186_s12931_022_02045_2
crossref_primary_10_1007_s10654_020_00626_3
crossref_primary_10_35627_2219_5238_2023_31_11_66_73
crossref_primary_10_2147_JIR_S324323
crossref_primary_10_1080_17476348_2022_2149496
crossref_primary_10_1177_00469580231214469
crossref_primary_10_1186_s12890_022_02040_9
crossref_primary_10_56294_mw2024496
Cites_doi 10.5603/ARM.2017.0016
10.1016/j.envint.2018.06.016
10.1016/j.jhep.2018.12.001
10.1016/S0140-6736(07)61696-1
10.1016/S0140-6736(15)60264-1
10.1001/jama.2013.284692
10.3399/bjgp18X699389
10.5588/ijtld.14.0446
10.1186/1465-9921-8-89
10.3390/ijerph14080841
10.1183/09059180.00009113
10.1093/eurpub/ckx109
10.2147/COPD.S147628
10.1080/08870446.2017.1325890
10.1111/crj.12028
10.1016/j.chest.2016.08.1474
10.1016/S2213-2600(14)70008-6
10.1055/s-0037-1603766
10.1016/j.envint.2019.04.026
10.1183/13993003.00559-2017
10.21037/jtd.2017.11.91
ContentType Journal Article
Copyright COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2020
Copyright_xml – notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2020
DBID AAYXX
CITATION
NPM
3V.
7QL
7U7
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12931-020-1291-8
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Toxicology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
Toxicology Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
Publicly Available Content Database
PubMed


Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Statistics
EISSN 1465-993X
EndPage 13
ExternalDocumentID oai_doaj_org_article_95dfc9d9760e435185687957ed46f3c6
PMC7014719
A616396491
32046720
10_1186_s12931_020_1291_8
Genre Journal Article
GeographicLocations China
Singapore
GeographicLocations_xml – name: China
– name: Singapore
GrantInformation_xml – fundername: Key Technologies Research and Development Program
  grantid: 2016YFC1304500
– fundername: Young Scientists Fund
  grantid: 81700052
– fundername: Natural Science Foundation of China
  grantid: 81670020
– fundername: ;
  grantid: 81670020
– fundername: ;
  grantid: 81700052
– fundername: ;
  grantid: 2016YFC1304500
GroupedDBID ---
0R~
29P
2WC
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
FRP
M~E
NPM
PMFND
7QL
7U7
7U9
7XB
8FK
AZQEC
C1K
DWQXO
H94
K9.
M7N
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c560t-8d6b3ba4a5bd2e231052b139a156afd83776d51d1f9f7ef9d666d77e6be4b70b3
IEDL.DBID M48
ISSN 1465-993X
1465-9921
IngestDate Wed Aug 27 01:29:26 EDT 2025
Thu Aug 21 18:33:16 EDT 2025
Fri Jul 11 11:43:01 EDT 2025
Sat Aug 23 14:58:15 EDT 2025
Tue Jun 17 21:50:45 EDT 2025
Tue Jun 10 20:48:59 EDT 2025
Thu Jan 02 23:00:43 EST 2025
Thu Apr 24 23:00:59 EDT 2025
Tue Jul 01 02:43:17 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Chronic obstructive pulmonary disease
Chronic respiratory diseases
Global
Asthma
Incidence
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-8d6b3ba4a5bd2e231052b139a156afd83776d51d1f9f7ef9d666d77e6be4b70b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2161-6168
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12931-020-1291-8
PMID 32046720
PQID 2357214895
PQPubID 42864
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_95dfc9d9760e435185687957ed46f3c6
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7014719
proquest_miscellaneous_2354142739
proquest_journals_2357214895
gale_infotracmisc_A616396491
gale_infotracacademiconefile_A616396491
pubmed_primary_32046720
crossref_primary_10_1186_s12931_020_1291_8
crossref_citationtrail_10_1186_s12931_020_1291_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-02-11
PublicationDateYYYYMMDD 2020-02-11
PublicationDate_xml – month: 02
  year: 2020
  text: 2020-02-11
  day: 11
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Respiratory research
PublicationTitleAlternate Respir Res
PublicationYear 2020
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References A Descatha (1291_CR13) 2018; 119
L Nathell (1291_CR22) 2007; 8
DO Abegunde (1291_CR7) 2007; 370
F Nissen (1291_CR25) 2018; 68
RC Jones (1291_CR23) 2014; 2
Coralynn Sack (1291_CR16) 2017; 50
M Ng (1291_CR18) 2014; 311
V Bilano (1291_CR20) 2015; 385
1291_CR6
E Stafyla (1291_CR24) 2018; 13
N Khaltaev (1291_CR1) 2017; 9
P Burney (1291_CR9) 2015; 19
1291_CR11
1291_CR10
KM Antoniou (1291_CR15) 2014; 23
S Prazakova (1291_CR14) 2014; 8
S Sahni (1291_CR8) 2017; 85
1291_CR2
R West (1291_CR19) 2017; 32
1291_CR4
P Yin (1291_CR5) 2016; 150
G Ferrante (1291_CR3) 2017; 27
M Bonifazi (1291_CR17) 2017; 38
Z Liu (1291_CR12) 2019; 70
J Li (1291_CR21) 2019; 128
References_xml – volume: 85
  start-page: 97
  year: 2017
  ident: 1291_CR8
  publication-title: Adv Respir Med
  doi: 10.5603/ARM.2017.0016
– volume: 119
  start-page: 366
  year: 2018
  ident: 1291_CR13
  publication-title: Environ Int
  doi: 10.1016/j.envint.2018.06.016
– volume: 70
  start-page: 674
  year: 2019
  ident: 1291_CR12
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2018.12.001
– volume: 370
  start-page: 1929
  year: 2007
  ident: 1291_CR7
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)61696-1
– volume: 385
  start-page: 966
  year: 2015
  ident: 1291_CR20
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)60264-1
– volume: 311
  start-page: 183
  year: 2014
  ident: 1291_CR18
  publication-title: JAMA
  doi: 10.1001/jama.2013.284692
– ident: 1291_CR10
– ident: 1291_CR6
– volume: 68
  start-page: e775
  year: 2018
  ident: 1291_CR25
  publication-title: Br J Gen Pract
  doi: 10.3399/bjgp18X699389
– volume: 19
  start-page: 10
  year: 2015
  ident: 1291_CR9
  publication-title: Int J Tuberc Lung Dis
  doi: 10.5588/ijtld.14.0446
– volume: 8
  start-page: 89
  year: 2007
  ident: 1291_CR22
  publication-title: Respir Res
  doi: 10.1186/1465-9921-8-89
– ident: 1291_CR4
  doi: 10.3390/ijerph14080841
– volume: 23
  start-page: 40
  year: 2014
  ident: 1291_CR15
  publication-title: Eur Respir Rev
  doi: 10.1183/09059180.00009113
– volume: 27
  start-page: 1110
  year: 2017
  ident: 1291_CR3
  publication-title: Eur J Pub Health
  doi: 10.1093/eurpub/ckx109
– volume: 13
  start-page: 487
  year: 2018
  ident: 1291_CR24
  publication-title: Int J Chron Obstruct Pulmon Dis
  doi: 10.2147/COPD.S147628
– volume: 32
  start-page: 1018
  year: 2017
  ident: 1291_CR19
  publication-title: Psychol Health
  doi: 10.1080/08870446.2017.1325890
– volume: 8
  start-page: 1
  year: 2014
  ident: 1291_CR14
  publication-title: Clin Respir J
  doi: 10.1111/crj.12028
– volume: 150
  start-page: 1269
  year: 2016
  ident: 1291_CR5
  publication-title: Chest
  doi: 10.1016/j.chest.2016.08.1474
– volume: 2
  start-page: 267
  year: 2014
  ident: 1291_CR23
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(14)70008-6
– volume: 38
  start-page: 437
  year: 2017
  ident: 1291_CR17
  publication-title: Semin Respir Crit Care Med
  doi: 10.1055/s-0037-1603766
– volume: 128
  start-page: 46
  year: 2019
  ident: 1291_CR21
  publication-title: Environ Int
  doi: 10.1016/j.envint.2019.04.026
– ident: 1291_CR11
– ident: 1291_CR2
– volume: 50
  start-page: 1700559
  issue: 6
  year: 2017
  ident: 1291_CR16
  publication-title: European Respiratory Journal
  doi: 10.1183/13993003.00559-2017
– volume: 9
  start-page: 4676
  year: 2017
  ident: 1291_CR1
  publication-title: J Thorac Dis
  doi: 10.21037/jtd.2017.11.91
SSID ssj0017875
Score 2.5965233
Snippet Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs...
Background Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence...
Abstract Background Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 49
SubjectTerms Age
Asthma
Chronic diseases
Chronic illnesses
Chronic obstructive pulmonary disease
Chronic respiratory diseases
Datasets
Generalized linear models
Geriatrics
Global
Incidence
Injury analysis
Lung diseases
Males
Morbidity
Obstructive lung disease
Older people
Pneumoconiosis
Respiratory diseases
Respiratory tract diseases
Risk analysis
Risk factors
Sarcoidosis
Sexes
Silicosis
Socioeconomic factors
Statistical analysis
Statistics
Trends
World health
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9RAEB6kD9IXUdvaaC0rCEIhNJv9lX2sYilCfWqhb0v2FxYkV-6u_39nkr3zgmBffL3dQHYyk2--m8k3AJ9VCJ3xUtUi6lhLmXXd25xqxIIutEJHkYgoXv_UV7fyx5262xn1RT1hkzzwZLhzq2IONiJqNgmhHeFF03xsk6LUWYRRbBsxb0OmSv0A3VCVGibv9PmKUA1pc0udCJbX3QyFRrH-v1_JO5g075fcAaDL1_CqZI7sYrrjN_AiDW_h5XWpjR_AzdTeyu4H9rAkEW-KWdYPkdHf6ePoULbILExquGz5p8bOSpVmxehjE8YROth6wRC0zSHcXn6_-XZVl5kJdcDcZV13UXvhe9krH9tEyZtqPWZ5PfK0Pkeko0ZHxSPPNpuUbUT6Eo1J2ifpTePFEewNiyEdA4sJcwWhUqK0DpHeIhdEgihkRxo4RlXQbGzoQhEUp7kWv91ILDrtJrM7NLsjs7uugrPtJQ-Tmsa_Nn-lB7PdSELY4w_oHq64h3vOPSr4Qo_VUbjizYW-fHWARyThK3ehMSG1WlpewclsJ4ZZmC9vHMOVMF850gpqkVBaNMan7TJdSa1rQ1o8jnskl2gxW8G7yY-2RxJtg0DVNhWYmYfNzjxfGe5_jSLgBrmt4fb9_zDSB9hvKTZozg0_gb318jF9xFxr7U_HsHoCZqwgvw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7aFEovpe86SYsKhUJBxLL1sE4lLQ2hkJ4S2JuwHm4Dxd7ubv5_Z2ytE1PI1ZLAkmY032hG3wB8VCE0xkvF66gjl7LTvLVd4mgLmlDVOtaJHMWLn_r8Sv5YqVW-cNvmtMr9mTge1HEIdEd-QrQsFWJ3q76s_3KqGkXR1VxC4yE8Iuoykmqzmh0ugcKoptdFiltbiRzVFI0-2ZKdQ0e6otwEK3izsEsjff__h_QdK7XMoLxjks6ewdOMJdnptPnP4UHqX8DjixwtfwmXU8Iru-7ZekO03qTFrO0jowv2sZgoGzoWJn5ctrmNurMct9kyen7CBBoTthsYmnHzCq7Ovl9-O-e5igIPiGZ2vIna176VrfKxSgTnVOUR97XoubVdRAfV6KhEFJ3tTOpsRIcmGpO0T9Kb0tev4aAf-vQWWEyIHmqVEgE9tP0WvUN0GWvZECuOUQWU-zV0IVOMU6WLP250NRrtpmV3uOyOlt01BXyeh6wnfo37On-ljZk7EjX2-GHY_HJZ05xVsQs2IswqE2JBxCOaCqqbFKXu6qAL-ETb6kiB8edCm98h4BSJCsudaoSoVksrCjhe9ETFC8vmvWC4rPhbdyumBXyYm2kkJbP1abgZ-0ghccVsAW8mOZqnVFclmq6qLMAsJGwx52VLf_17pAU36O0aYQ_v_60jeFKR1FNNG3EMB7vNTXqHuGrn34_K8w9m1xrg
  priority: 102
  providerName: ProQuest
Title Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017
URI https://www.ncbi.nlm.nih.gov/pubmed/32046720
https://www.proquest.com/docview/2357214895
https://www.proquest.com/docview/2354142739
https://pubmed.ncbi.nlm.nih.gov/PMC7014719
https://doaj.org/article/95dfc9d9760e435185687957ed46f3c6
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3batwwEB1ygZKX0qY3p-miQqFQcOuLLtZDCJuSEBY2lDYL-yZsSU4DwU69G0j-PjO2dxPTkCfDSjaWZmbnHEs6A_BFWJupgoswddKFnJcyzHXpQ8wFmU1S6VJPRHF6Jk9nfDIX8w1YlbfqJ3DxJLWjelKz5ur77b-7Qwz4gzbgM_ljQTkLSXFC-wx0HGabsI2JSVFBgyl_WFRA3xTdYSMRap3E_SLnk48YpKlWzf___-xHSWu4ofJRhjp5BS97aMnGnS-8hg1f7cKLab94vgs7BCw7XeY3cN5thmWXFbtuSPKbIpzllWP08b0tNMrqktlOO5c1DyvyrF_TWTA6msJiTDRsWTNM8eotzE6Oz3-ehn2FhdAi0lmGmZNFWuQ8F4VLPEE9kRSICXNkdXnpkLwq6UTs4lKXypfaIdlxSnlZeF6oqEjfwVZVV_4DMOcRWaTCewKBiAs0MkekkynPSDFHiQCi1YQa28uPUxWMK9PSkEyazgYGbWDIBiYL4Nv6lutOe-O5zkdkpXVHks1uf6ibC9NHodHClVY7hGCRR5yIWEVSsXXlHZdlamUAX8nGhtwNX87m_RkFHCLJZJmxRPiqJddxAPuDnhiUdti88hKz8mlDykIJ0k-Nk_F53Ux30ka3ytc3bR8ec5wxHcD7zqnWQ0qTCNNaEgWgBu42GPOwpbr820qGK2TCKtZ7z7_1R9hJKASo3k28D1vL5sZ_Qsy1LEawqeZqBNvj8eTPBK9Hx2e_fo_aLxijNsruAb4qJtA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxLMEChgJhIQUNXb8iA8IlUe1pd2ettLeTBI7UAkly-5WiD_Fb2QmyaaNkHrrde2s4vGM5_sy4xmA16osM1NIFade-1jKSse5rUKMviArRap9GogoTk_05FR-nav5Fvzd3IWhtMrNmdge1L4p6Rv5HpVlEYjdrfqw-BVT1yiKrm5aaHRqcRT-_EbKtnp_-Bn3940QB19mnyZx31UgLtG7r-PM6yItcpmrwotA8EaJAnFQjkwmrzwSNqO94p5XtjKhsh4Bvjcm6CLIwiRFiv97A26i402I7Jn5QPA4Kr_qbjOp2FrB-ygqz_TeivwqEndBuRCWx9nID7btAv53Cpe84jhj85ILPLgHd3vsyvY7ZbsPW6F-ALemfXT-Icy6BFt2VrPFksqI06nB8toz-qDfNi9lTcXKrh4vW15E-VkfJ1oxuu7CODovtm4YwgbzCE6vRb6PYbtu6vAEmA-IVlIVAgFLxBoW2ShS1FRmVIXHqAiSjQxd2Zc0p84aP11LbTLtOrE7FLsjsbssgnfDI4uunsdVkz_SxgwTqRR3-0Oz_O56y3ZW-aq0HmFdEhB7Iv7R1MDdBC91lZY6gre0rY4ODHy5Mu_vPeASqfSW29cIia2WlkewO5qJhl6OhzeK4fqDZuUuzCKCV8MwPUnJc3Vozts5kkuUmI1gp9OjYUmpSNBViiQCM9Kw0ZrHI_XZj7YMuUF2bbh9evVrvYTbk9n02B0fnhw9gzuCLID66fBd2F4vz8NzxHTr4kVrSAy-Xbfl_gOialhL
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trends+in+prevalence+and+incidence+of+chronic+respiratory+diseases+from+1990+to+2017&rft.jtitle=Respiratory+research&rft.au=Xie%2C+Min&rft.au=Liu%2C+Xiansheng&rft.au=Cao%2C+Xiaopei&rft.au=Guo%2C+Mingzhou&rft.date=2020-02-11&rft.pub=BioMed+Central+Ltd&rft.issn=1465-9921&rft.volume=21&rft.issue=1&rft_id=info:doi/10.1186%2Fs12931-020-1291-8&rft.externalDocID=A616396491
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon